Muscle-bone interactions: Basic and clinical aspects

Endocrine

Volumn 45, Issue 2, 2014, Pages 165-177

  Cianferotti, Luisella ^a   Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Endocrine; Fracture healing; Myocyte; Myokine; Osteoblast; Osteocyte

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL MODEL; BIOMECHANICS; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERALIZATION; BONE REMODELING; BONE STRESS; BONE TISSUE; FRACTURE; FUNCTIONAL ASSESSMENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUSCLE EXERCISE; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL FUNCTION; MUSCULOSKELETAL INJURY; NONHUMAN; OSTEOPOROSIS; PARACRINE SIGNALING; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SARCOPENIA; SKELETAL MUSCLE; WOUND HEALING;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE AND BONES; BONE REMODELING; CELLULAR MICROENVIRONMENT; HUMANS; MODELS, ANIMAL; MUSCLE, SKELETAL; PARACRINE COMMUNICATION;

EID: 84896702143     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0026-8     Document Type: Review

References (149)

1. D.B. Burr, A.G. Robling, C.H. Turner, Effects of biomechanical stress on bones in animals. Bone 30, 781-786 (2002)
2. Y.X. Qin, H. Lam, S. Ferreri, C. Rubin, Dynamic skeletal muscle stimulation and its potential in bone adaptation. J. Musculoskelet. Neuronal Interact. 10, 12-24 (2010)
3. D.J. DiGirolamo, T.L. Clemens, S. Kousteni, The skeleton as an endocrine organ. Nat. Rev. Rheumatol. 8, 674-683 (2012)
4. G. Karsenty, F. Oury, Biology without walls: the novel endocrinology of bone. Ann. Rev. Physiol. 74, 87-105 (2012)
5. S.C. Forbes, J.P. Little, D.G. Candow, Exercise and nutritional interventions for improving aging muscle health. Endocrine 42, 29-38 (2012)
6. B.K. Pedersen, Muscles and their myokines. J. Exp. Biol. 214, 337-346 (2011)
7. F. Norheim, T. Raastad, B. Thiede, A.C. Rustan, C.A. Drevon, F. Haugen, Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301, E1013-E1021 (2011)
8. S. Bortoluzzi, P. Scannapieco, A. Cestaro, G.A. Danieli, S. Schiaffino, Computational reconstruction of the human skeletal muscle secretome. Proteins 62, 776-792 (2006)
9. B.K. Pedersen, M.A. Febbraio, Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457-465 (2012)
10. M.W. Hamrick, The skeletal muscle secretome: an emerging player in muscle-bone crosstalk. BoneKEy Reports 1, Article number: 60 (2012). doi: 10.1038/bonekey.2012.60
11. E. Seeman, J.L. Hopper, N.R. Young, C. Formica, P. Goss, C. Tsalamandris, Do genetic factors explain associations between muscle strength, lean mass, and bone density? a twin study. Am. J. Physiol. 270, E320-E327 (1996)
12. D. Karasik, D.P. Kiel, Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 46, 1226-1237 (2010)
13. D. Karasik, C.L. Cheung, Y. Zhou, L.A. Cupples, D.P. Kiel, S. Demissie, Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes? J. Bone Miner. Res. 27, 319-330 (2012)
14. C. Cooper, W. Dere, W. Evans, J.A. Kanis, R. Rizzoli, A.A. Sayer, C.C. Sieber, J.M. Kaufman, G. Abellan van Kan, S. Boonen, J. Adachi, B. Mitlak, Y. Tsouderos, Y. Rolland, J.Y. Reginster, Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 23, 1839-1848 (2012)
15. D. Karasik, M. Cohen-Zinder, The genetic pleiotropy of musculoskeletal aging. Front Physiol. 3, 303 (2012)
16. A. Tajar, I.T. Huhtaniemi, T.W. O'Neill, J.D. Finn, S.R. Pye, D.M. Lee, G. Bartfai, S. Boonen, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, F. Labrie, M.E. Lean, N. Pendleton, M. Punab, D. Vanderschueren, F.C. Wu, EMAS Group, Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J. Clin. Endocrinol. Metab. 97, 1508-1516 (2012)
17. M. Spitzer, G. Huang, S. Basaria, T.G. Travison, S. Bhasin, Risks and benefits of testosterone therapy in older men. Nat. Rev. Endocrinol. 9, 414-424 (2013)
18. P. Lips, N.M. van Schoor, The effect of vitamin D on bone and osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 25, 585-591 (2011)
19. H.A. Bischoff-Ferrari, Relevance of vitamin D in muscle health. Rev. Endocr. Metab. Disord. 13, 71-77 (2012)
20. L. Ceglia, S.S. Harris, Vitamin D and its role in skeletal muscle. Calcif. Tissue Int. 92, 151-162 (2013)
21. C.M. Girgis, R.J. Clifton-Bligh, M.W. Hamrick, M.F. Holick, J.E. Gunton, The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev. 34, 33-83 (2013)
22. L. Schubert, H.F. DeLuca, Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch. Biochem. Biophys. 500, 157-161 (2010)
23. H.F. Wang, Y. DeLuca, Is the vitamin D receptor found in muscle? Endocrinology 152, 354-363 (2011)
24. K.B. Hagen, H. Dagfinrud, R.H. Moe, N. Østerås, I. Kjeken, M. Grotle, G. Smedslund, Exercise therapy for bone and muscle health: an overview of systematic reviews. BMC Med. 10, 167 (2012)
25. A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535-559 (2008)
26. C.G. Tahimic, Y. Wang, D.D. Bikle, Anabolic effects of IGF-1 signaling on the skeleton. Front. Endocrinol. (Lausanne) 4, 6 (2013). doi: 10.3389/fendo.2013.00006. Epub 2013 Feb 4
27. S. Perrini, L. Laviola, M.C. Carreira, A. Cignarelli, A. Natalicchio, F. Giorgino, The GH/IGF1 axis and signalling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201-210 (2010)
28. J.K. Park, J.W. Hong, C.O. Kim, S.W. Kim, C.Y. Lim, Y.S. Chung, S.W. Kim, E.J. Lee, Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause. J. Am. Geriatr. Soc. 59, 944-947 (2011)
29. M.D. Mavalli, D.J. Di Girolamo, Y. Fan, R.C. Riddle, K.S. Campbell, T. van Groen, S.J. Frank, M.A. Sperling, K.A. Esser, M.M. Bamman, T.L. Clemens, Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 120, 4007-4020 (2010)
30. N.K. Pollock, Muscle and bone. IBMS BoneKEy 9, Article number: 25 (2012). doi: 10.1038/bonekey.2012.25
31. M.A. Bredella, P.K. Fazeli, B. Lecka-Czernik, C.J. Rosen, A. Klibanski, IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women. Bone 53, 336-339 (2013)
32. J.N. Farr, N. Charkoudian, J.N. Barnes, D.G. Monroe, L.K. McCready, E.J. Atkinson, S. Amin, L.J. Melton 3rd, M.J. Joyner, S. Khosla, Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women. J. Clin. Endocrinol. Metab. 97, 4219-4227 (2012)
33. P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, E.A. Boström, J.H. Choi, J.Z. Long, S. Kajimura, M.C. Zingaretti, B.F. Vind, H. Tu, S. Cinti, K. Højlund, S.P. Gygi, B.M. Spiegelman, A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468 (2012)
34. K. Redlich, J.S. Smolen, Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug Discov 11, 234-250 (2012)
35. D.J. Glass, Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 225-229 (2010)
36. W.S. Lee, W.H. Cheung, L. Qin, N. Tang, K.S. Leung, Age-associated decrease of type IIA/B human skeletal muscle fibers. Clin. Orthop. Relat. Res. 450, 231-237 (2006)
37. A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age ageing 39, 412-423 (2010)
38. R.A. Fielding, B. Vellas, W.J. Evans, S. Bhasin, J.E. Morley, A.B. Newman, G. Abellan van Kan, S. Andrieu, J. Bauer, D. Breuille, T. Cederholm, J. Chandler, C. De Meynard, L. Donini, T. Harris, A. Kannt, Keime, F. Guibert, G. Onder, D. Papanicolaou, Y. Rolland, D. Rooks, C. Sieber, E. Souhami, S. Verlaan, M. Zamboni, Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249-256 (2011)
39. J.P. Gumucio, C.L. Mendias, Atrogin-1, MuRF-1, and sarcopenia. Endocrine 43, 12-21 (2013)
40. E. Anliker, M. Toigo, Functional assessment of the muscle-bone unit in the lower leg. J. Musculoskelet. Neuronal Interact. 12, 46-55 (2012)
41. T. Montalcini, V. Migliaccio, F. Yvelise, S. Rotundo, E. Mazza, A. Liberato, A. Pujia, Reference values for handgrip strength in young people of both sexes. Endocrine 43, 342-345 (2013)
42. H.H. Bolotin, A new perspective on the causal influence of soft tissue composition on DXA-measured in vivo bone mineral density. J. Bone Miner. Res. 13, 1739-1746 (1998)
43. B.S. Zemel, Quantitative computed tomography and computed tomography in children. Curr. Osteoporos. Rep. 9, 284-290 (2011)
44. A.M. Cheung, J.D. Adachi, D.A. Hanley, D.L. Kendler, K.S. Davison, R. Josse, J.P. Brown, L.G. Ste-Marie, R. Kremer, M.C. Erlandson, L. Dian, A.J. Burghardt, S.K. Boyd, High-Resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr. Osteoporos. Rep. 11(2), 136-146 (2013)
45. E. Schoenau, C.M. Neu, B. Beck, F. Manz, F. Rauch, Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J. Bone Miner. Res. 17, 1095-1101 (2002)
46. K.L. Butner, K.W. Creamer, S.M. Nickols-Richardson, S.F. Clark, W.K. Ramp, W.G. Herbert, Fat and muscle indices assessed by pQCT: relationships with physical activity and type 2 diabetes risk. J. Clin. Densitom. 15, 355-361 (2012)
47. S. Coupaud, L.P. Jack, K.J. Hunt, K.J. Hunt, D.B. Allan, Muscle and bone adaptations after treadmill training in incomplete spinal cord injury: a case study using peripheral quantitative computed tomography. J. Musculoskelet. Neuronal Interact. 9, 288-297 (2009)
48. N. Stolzenberg, D.L. Belavy, G. Beller, G. Armbrecht, J. Semler, D. Felsenberg, Bone strength and density via pQCT in post-menopausal osteopenic women after 9 months resistive exercise with whole body vibration or proprioceptive exercise. J. Musculoskelet. Neuronal Interact. 13, 66-76 (2013)
49. A.A. Sayer, E.M. Dennison, H.E. Syddall, K. Jameson, H.J. Martin, C. Cooper, The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J. Gerontol. A 63, 835-840 (2008)
50. J.N. Farr, J.L. Funk, Z. Chen, J.R. Lisse, R.M. Blew, V.R. Lee, M. Laudermilk, T.G. Lohman, S.B. Going, Skeletal muscle fat content is inversely associated with bone strength in young girls. J. Bone Miner. Res. 26, 2217-2225 (2011)
51. A.K. Wong, A. Bhargava, K. Beattie, K. Beattie, C.L. Gordon, L. Pickard, C.E. Webber, A. Papaioannou, J. Adachi, J. Adachi, Muscle density, a surrogate of intermuscular adiposity derived from pQCT, is an independent correlate of fractures in women. J. Bone Miner. Res. 26(Suppl 1), 2341-2357 (2011)
52. T. Lang, J.A. Cauley, F. Tylavsky, D. Bauer, S. Cummings, T.B. Harris, Health ABC Study, Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J. Bone Miner. Res. 25, 513-519 (2010)
53. K. Deere, A. Sayers, H. Viljakainen, D. Lawlor, N. Sattar, J. Kemp, W. Fraser, J. Tobias, Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females. J. Clin. Endocrinol. Metab. 98(6), E1041 (2013)
54. J.F. Baker, M. Davis, R. Alexander, B.S. Zemel, S. Mostoufi-Moab, J. Shults, M. Sulik, D.J. Schiferl, M.B. Leonard, Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 53, 34-41 (2013)
55. J.L. Ferretti, R.F. Capozza, G.R. Cointry, S.L. García, H. Plotkin, M.L. Alvarez Filgueira, J.R. Zanchetta, Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone 22, 683-690 (1998)
56. H. Zhang, X. Chai, S. Li, Z. Zhang, L. Yuan, H. Xie, H. Zhou, X. Wu, Z. Sheng, E. Liao, Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women. Endocrine 43, 643-650 (2013)
57. N.K. Lebrasseur, S.J. Achenbach, L.J. Melton 3rd, S. Amin, S. Khosla, Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J. Bone Miner. Res. 27, 2159-2169 (2012)
58. H.M. Frost, Muscle strength, bone mass, and age-related bone loss. J. Bone Miner. Res. 12, 1547-1551 (1997)
59. E. Schoenau, From mechanostat theory to development of the "functional muscle-bone-unit". J. Musculoskelet. Neuronal Interact. 5, 232-238 (2005)
60. L.F. Bonewald, The amazing osteocyte. J. Bone Miner. Res. 26, 229-238 (2011)
61. C. Rubin, A.S. Turner, S. Bain, C. Mallinckrodt, K. McLeod, Anabolism: low mechanical signals strengthen long bones. Nature 412, 603-604 (2001)
62. F. Rauch, D.A. Bailey, A. Baxter-Jones, R. Mirwald, R. Faulkner, The 'muscle-bone unit' during the pubertal growth spurt. Bone 34, 771-775 (2004)
63. O. Fricke, R. Beccard, O. Semler, E. Schoenau, Analyses of muscular mass and function: the impact on bone mineral density and peak muscle mass. Pediatr. Nephrol. 25, 2393-2400 (2010)
64. L. Xu, Q. Wang, Q. Wang, A. Lyytikäinen, T. Mikkola, E. Völgyi, S. Cheng, P. Wiklund, E. Munukka, P. Nicholson, M. Alén, S. Cheng, Concerted actions of insulin-like growth factor 1, testosterone, and estradiol on peripubertal bone growth: a 7-year longitudinal study. J. Bone Miner. Res. 26, 2204-2211 (2011)
65. G.L. Klein, L.A. Fitzpatrick, C.B. Langman, T.J. Beck, T.O. Carpenter, V. Gilsanz, I.A. Holm, M.B. Leonard, B.L. Specker, ASBMR Group, The state of pediatric bone: summary of the ASBMR pediatric bone initiative. J. Bone Miner. Res. 20, 2075-2081 (2005)
66. M.B. Leonard, A. Elmi, S. Mostoufi-Moab, J. Shults, J.M. Burnham, M. Thayu, L. Kibe, R.J. Wetzsteon, B.S. Zemel, Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J. Clin. Endocrinol. Metab. 95, 1681-1689 (2010)
67. J.M. Burnham, J. Shults, H. Sembhi, B.S. Zemel, M.B. Leonard, The dysfunctional muscle-bone unit in juvenile idiopathic arthritis. J. Musculoskelet. Neuronal Interact. 6, 351-352 (2006)
68. A. Tsampalieros, P. Gupta, M.R. Denburg, J. Shults, B.S. Zemel, S. Mostoufi-Moab, R.J. Wetzsteon, R.M. Herskovitz, K.M. Whitehead, M.B. Leonard, Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J. Bone Miner. Res. 28, 480-488 (2013)
69. A. LeBlanc, R. Rowe, V. Schneider, H. Evans, T. Hedrick, Regional muscle loss after short duration spaceflight. Aviat. Space Environ. Med. 66, 1151-1154 (1995)
70. T. Trappe, Influence of aging and long-term unloading on the structure and function of human skeletal muscle. Appl. Physiol. Nutr. Metab. 34, 459-464 (2009)
71. M.L. Bianchi, A. Mazzanti, E. Galbiati, S. Saraifoger, A. Dubini, F. Cornelio, L. Morandi, Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos. Int. 14, 761-767 (2003)
72. Y. Shirazi-Fard, J.S. Kupke, S.A. Bloomfield, H.A. Hogan, Discordant recovery of bone mass and mechanical properties during prolonged recovery from disuse. Bone 52, 433-443 (2013)
73. P. Szulc, S. Boutroy, S. Boutroy, N. Vilayphiou, M. Schoppet, M. Rauner, R. Chapurlat, C. Hamann, L.C. Hofbauer, Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study. J. Bone Miner. Res. 28(8), 1760-1770 (2013)
74. P. Szulc, S. Blaizot, S. Boutroy, N. Vilayphiou, S. Boonen, R. Chapurlat, Impaired bone microarchitecture at the distal radius in older men with low muscle mass and grip strength: the STRAMBO study. J. Bone Miner. Res. 28, 169-178 (2013)
75. A. Sharir, T. Stern, C. Rot, R. Shahar, E. Zelzer, Muscle force regulates bone shaping for optimal load-bearing capacity during embryogenesis. Development 138, 3247-3259 (2011)
76. N.C. Nowlan, J. Sharpe, K.A. Roddy, P.J. Prendergast, P. Murphy, Mechanobiology of embryonic skeletal development: insights from animal models. Birth Defects Res. C 90, 203-213 (2010)
77. J. Kahn, Y. Shwartz, E. Blitz, S. Krief, A. Sharir, D.A. Breitel, R. Rattenbach, F. Relaix, P. Maire, R.B. Rountree, D.M. Kingsley, E. Zelzer, Muscle contraction is necessary to maintain joint progenitor cell fate. Dev. Cell 16, 734-743 (2009)
78. J.G. Hall, Analysis of Pena Shokeir phenotype. Am. J. Med. Genet. 25, 99-117 (1986)
79. P. Juffer, R.T. Jaspers, P. Lips, A.D. Bakker, J. Klein-Nulend, Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes. Am. J. Physiol. Endocrinol. Metab. 302, E389-E395 (2012)
80. N.C. Nowlan, C. Bourdon, G. Dumas, S. Tajbakhsh, P.J. Prendergast, P. Murphy, Developing bones are differentially affected by compromised skeletal muscle formation. Bone 46, 1275-1285 (2010)
81. N.C. Nowlan, G. Dumas, S. Tajbakhsh, P.J. Prendergast, P. Murphy, Biophysical stimuli induced by passive movements compensate for lack of skeletal muscle during embryonic skeletogenesis. Biomech. Model. Mechanobiol. 11, 207-219 (2012)
82. S.E. Warner, D.A. Sanford, B.A. Becker, S.D. Bain, S. Srinivasan, T.S. Gross, Botox induced muscle paralysis rapidly degrades bone. Bone 38, 257-264 (2006)
83. D. Joulia-Ekaza, G. Cabello, The myostatin gene: physiology and pharmacological relevance. Curr. Opin. Pharmacol. 7, 310-315 (2007)
84. A.C. McPherron, A.M. Lawler, S.J. Lee, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90 (1997)
85. A.C. McPherron, S.J. Lee, Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94, 12457-12461 (1997)
86. M. Schuelke, K.R. Wagner, L.E. Stolz, C. Hübner, T. Riebel, W. Kömen, T. Braun, J.F. Tobin, S.J. Lee, Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350, 2682-2688 (2004)
87. T.A. Zimmers, M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, K.N. Tomkinson, A.C. McPherron, N.M. Wolfman, S.J. Lee, Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488 (2002)
88. S. Reisz-Porszasz, S. Bhasin, J.N. Artaza, R. Shen, I. Sinha-Hikim, A. Hogue, T.J. Fielder, N.F. Gonzalez-Cadavid, Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am. J. Physiol. Endocrinol. Metab. 285, E876-E888 (2003)
89. M.W. Hamrick, A.C. McPherron, C.O. Lovejoy, Bone mineral content and density in the humerus of myostatin-deficient mice. Calcif. Tissue Int. 71, 63-68 (2002)
90. M.W. Hamrick, Increased bone mineral density in the femora of GDF8 knockout mice. Anat. Rec. 272, 388-391 (2003)
91. E. Montgomery, C. Pennington, M. Hamrick, Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat. Rec. 286, 814-822 (2005)
92. M.N. Elkasrawy, M.W. Hamrick, Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J. Musculoskelet. Neuronal Interact. 10, 56-63 (2010)
93. M.R. Morissette, J.C. Stricker, M.A. Rosenberg, C. Buranasombati, E.B. Levitan, M.A. Mittleman, A. Rosenzweig, Effects of myostatin deletion in aging mice. Aging Cell 8, 573-583 (2009)
94. M.W. Hamrick, T. Samaddar, C. Pennington, J. McCormick, Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J. Bone Miner. Res. 21, 477-483 (2006)
95. M.W. Hamrick, X. Shi, W. Zhang, C. Pennington, H. Thakore, M. Haque, B. Kang, C.M. Isales, S. Fulzele, K.H. Wenger, Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 40, 1544-1553 (2007)
96. T. Guo, W. Jou, T. Chanturiya, J. Portas, O. Gavrilova, A.C. McPherron, Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4, e4937 (2009)
97. C. Zhang, C. McFarlane, S. Lokireddy, S. Masuda, X. Ge, P.D. Gluckman, M. Sharma, R. Kambadur, Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183-193 (2012)
98. M. Elkasrawy, D. Immel, X. Wen, X. Liu, L.F. Liang, M.W. Hamrick, Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J. Histochem. Cytochem. 60, 22-30 (2012)
99. S. Lokireddy, I.W. Wijesoma, S. Bonala, M. Wei, S.K. Sze, C. McFarlane, R. Kambadur, M. Sharma, Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem. J. 446, 23-36 (2012)
100. Z.L. Zhang, J.W. He, Y.J. Qin, Y.Q. Hu, M. Li, H. Zhang, W.W. Hu, Y.J. Liu, J.M. Gu, Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos. Int. 19, 39-47 (2008)
101. K.M. Lakshman, S. Bhasin, C. Corcoran, L.A. Collins-Racie, L. Tchistiakova, S.B. Forlow, K. St Ledger, M.E. Burczynski, A.J. Dorner, E.R. Lavallie, Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Mol. Cell. Endocrinol. 302, 26-32 (2009)
102. P. Szulc, M. Schoppet, C. Goettsch, M. Rauner, T. Dschietzig, R. Chapurlat, L.C. Hofbauer, Endocrine and clinical correlates of myostatin serum concentration in men-the STRAMBO study. J. Clin. Endocrinol. Metab. 97, 3700-3708 (2012)
103. M.W. Hamrick IBMS BoneKEy Reports 1, Article number: 60 (2012). doi: 10.1038/bonekey.2012.60
104. R.A. Brekken, E.H. Sage, SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19, 816-827 (2001)
105. L.H. Jorgensen, S.J. Petersson, J. Sellathurai, D.C. Andersen, S. Thayssen, D.J. Sant, C.H. Jensen, H.D. Schrøder, Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J. Histochem. Cytochem. 57, 29-39 (2009)
106. B.R. Barnes, E.R. Szelenyi, G.L. Warren, M.L. Urso, Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 in responses to traumatic skeletal muscle injury. Am. J. Physiol. Cell Physiol. 297, C1501-C1508 (2009)
107. L.S. Quinn, B.G. Anderson, L. Strait-Bodey, A. Stroud, J. Argiles, Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. Endocrinol. Metab. 296, E191-E202 (2009)
108. B.K. Pedersen, F. Edward, Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J. Appl. Physiol. 107, 1006-1014 (2009)
109. M.N. Weitzmann, C. Roggia, G. Toraldo, L. Weitzmann, R. Pacifici, Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 110, 1643-1650 (2002)
110. W.M. Jackson, A.B. Aragon, J. Onodera, S.M. Koehler, Y. Ji, J.D. Bulken-Hoover, J.A. Vogler, R.S. Tuan, L.J. Nesti, Cytokine expression in muscle following traumatic injury. J. Orthop. Res. 29, 1613-1620 (2011)
111. K. Tanaka, E. Matsumoto, Y. Higashimaki, T. Katagiri, T. Sugimoto, S. Seino, H. Kaji, Role of osteoglycin in the linkage between muscle and bone. J. Biol. Chem. 287, 11616-11628 (2012)
112. K. Tanaka, E. Matsumoto, Y. Higashimaki, T. Sugimoto, S. Seino, H. Kaji, FAM5C is a soluble osteoblast differentiation factor linking muscle to bone. Biochem. Biophys. Res. Commun. 418, 134-139 (2012)
113. M.W. Hamrick, P.L. McNeil, S.L. Patterson, Role of muscle-derived growth factors in bone formation. J. Musculoskelet. Neuronal Interact. 10, 64-70 (2010)
114. K. Jähn, N. Lara-Castillo, L. Brotto, C.L. Mo, M.L. Johnson, M. Brotto, L.F. Bonewald, Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin. Eur. Cell Mater. 24, 197-209 (2012). Discussion 209-210
115. E.L. Abreu, M. Stern, M. Brotto, Bone-muscle interactions: ASBMR Topical Meeting, July 2012. IBMS BoneKEy 9, Article number: 239 (2012). doi: 10.1038/bonekey.2012.239
116. C. Mo, S. Romero-Suarez, L. Bonewald, M. Johnson, M. Brotto, Prostaglandin e2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat. Biotechnol. 6, 223-229 (2012)
117. G. Karsenty, Osteocalcin and the regulation of bone mass. ASBMR topical meeting on bone and skeletal muscle interaction. http://www.asbmr.org/ TopicalMeeting/2012/Webcast/Session6.aspx (2012)
118. S.I. Zacks, M.F. Sheff, Periosteal and metaplastic bone formation in mouse minced muscle regeneration. Lab. Invest. 46, 405-412 (1982)
119. P.S. Landry, A. Marino, K. Sadasivan, A. Albright, Effect of soft-tissue trauma on the early periosteal response of bone to injury. J. Trauma 48, 479-483 (2000)
120. S.E. Utvag, K.B. Iversen, O. Grundnes, O. Reikeras, Poor muscle coverage delays fracture healing in rats. Acta Orthop Scand. 73, 471-474 (2002)
121. H. Stein, S.M. Perren, J. Cordey, J. Kenwright, R. Mosheiff, M.J. Francis, The muscle bed-a crucial factor for fracture healing: a physiological concept. Orthopedics 25, 1379-1383 (2002)
122. M.M. Reverte, R. Dimitriou, N.K. Kanakaris, P.V. Giannoudis, What is the effect of compartment syndrome and fasciotomies on fracture healing in tibial fractures? Injury 42, 1402-1407 (2011)
123. L.E. Harry, A. Sandison, E.M. Paleolog, U. Hansen, M.F. Pearse, J. Nanchahal, Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J. Orthop. Res. 26, 1238-1244 (2008)
124. S. Gopal, S. Majumder, A.G. Batchelor, S.L. Knight, S.L. Knight, P. De Boer, R.M. Smith, Fix and flap: the radical orthopaedic and plastic treatment of severe open fractures of the tibia. J. Bone Joint Surg. Br. 82, 959-966 (2000)
125. A. Schindeler, R. Liu, D.G. Little, The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation 77, 12-18 (2009)
126. R. Liu, A. Schindeler, D.G. Little, The potential role of muscle in bone repair. J. Musculoskelet. Neuronal Interact. 10, 71-76 (2010)
127. G.E. Glass, J.K. Chan, A. Freidin, M. Feldmann, N.J. Horwood, J. Nanchahal, TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc. Natl. Acad. Sci. U S A 108, 1585-1590 (2011)
128. D.M. Cairns, P. Lee, T. Uchimura, C.R. Seufert, H. Kwon, L. Zeng, The role of muscle cells in regulating cartilage matrix production. J. Orthop. Res. 28, 529-536 (2010)
129. G. Duda, W. Taylor, T. Winkler, G. Matziolis, M. Heller, N. Haas, C. Perka, K.D. Schaser, Biomechanical, microvascular, and cellular factors promote muscle and bone re generation. Exerc. Sports Sci. Rev. 36, 64-70 (2008)
130. Y. Hao, Y. Ma, X. Wang, F. Jin, S. Ge, Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur. J. Orthop. Res. 30, 574-580 (2012)
131. E. Kellum, H. Starr, P. Arounleut, D. Immel, S. Fulzele, K. Wenger, M.W. Hamrick, Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression and callus bone volume. Bone 44, 17-23 (2009)
132. M.W. Hamrick, P. Arounleut, E. Kellum, M. Cain, D. Immel, L.F. Liang, Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. J. Trauma 69, 579-583 (2010)
133. L.D. Gillespie, M.C. Robertson, W.J. Gillespie, C. Sherrington, S. Gates, L.M. Clemson, S.E. Lamb, Interventions for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 9, 007146 (2012)
134. A. Mithal, J.P. Bonjour, S. Boonen, P. Burckhardt, H. Degens, G. El Hajj Fuleihan, R. Josse, P. Lips, J. Morales Torres, R. Rizzoli, N. Yoshimura, D.A. Wahl, C. Cooper, B. Dawson-Hughes, IOF CSA Nutrition Working Group, Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos. Int. 24(5), 1555 (2012)
135. J. Rittweger, Vibration as an exercise modality: how it may work, and what its potential might be. Eur. J. Appl. Physiol. 108, 877-904 (2010)
136. J. Rittweger, G. Beller, G. Armbrecht, E. Mulder, B. Buehring, U. Gast, F. Dimeo, H. Schubert, A. de Haan, D.F. Stegeman, H. Schiessl, D. Felsenberg, Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise. Bone 46, 137-147 (2010)
137. M.E. Chan, G. Uzer, C.T. Rubin, The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr. Osteoporos. Rep. 11, 36-44 (2013)
138. M.W. Hamrick, Myostatin (GDF-8) as a Therapeutic Target for the Prevention of Osteoporotic Fractures. IBMS BoneKEy. 7, 8-17 (2010). doi: 10.1138/20100423
139. K. Tsuchida, M. Nakatani, K. Hitachi, A. Uezumi, Y. Sunada, H. Ageta, K. Inokuchi, Activin signaling as an emerging target for therapeutic interventions. Cell. Commun. Signal. 7, 15-19 (2009)
140. A.D. Mitchell, R.J. Wall, In vivo evaluation of changes in body composition of transgenic mice expressing the myostatin pro domain using dual energy X-ray absorptiometry. Growth Dev. Aging 70, 25-37 (2007)
141. S.J. Lee, L.A. Reed, M.V. Davies, S. Girgenrath, M.E. Goad, K.N. Tomkinson, J.F. Wright, C. Barker, G. Ehrmantraut, J. Holmstrom, B. Trowell, B. Gertz, M.S. Jiang, S.M. Sebald, M. Matzuk, E. Li, L.F. Liang, E. Quattlebaum, R.L. Stotish, N.M. Wolfman, Regulation of muscle growth by multiple ligands signalling through activin type II receptors. Proc. Natl. Acad. Sci. U S A 102, 18117-18122 (2005)
142. S. Bogdanovich, T.O. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, R.S. Ahima, T.S. Khurana, Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421 (2002)
143. K.R. Wagner, J.L. Fleckenstein, A.A. Amato, R.J. Barohn, K. Bushby, D.M. Escolar, K.M. Flanigan, A. Pestronk, R. Tawil, G.I. Wolfe, M. Eagle, J.M. Florence, W.M. King, S. Pandya, V. Straub, P. Juneau, K. Meyers, C. Csimma, T. Araujo, R. Allen, S.A. Parsons, J.M. Wozney, E.R. Lavallie, J.R. Mendell, A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 63, 561-571 (2008)
144. N.K. LeBrasseur, T.M. Schelhorn, B.L. Bernardo, P.G. Cosgrove, P.M. Loria, T.A. Brown, Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J. Gerontol. A 64, 940-948 (2009)
145. P. Bialek, J. Parkington, L. Warner, M. St. Andre, L. Jian, D. Gavin, C. Wallace, J. Zhang, G. Yan, A. Root, H. Seeherman, P. Yaworsky, Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass. Bone 42(Suppl 1), S46 (2008)
146. V. Ferguson, R. Paietta, L. Stodieck, A. Hanson, M. Young, T. Bateman, M. Lemus, P. Kostenuik, E. Jiao, X. Zhou, J. Lu, W. Simonet, D. Lacey, H. Han,
147. K.M. Attie, N.G. Borgstein, Y. Yang, C.H. Condon, D.M. Wilson, A.E. Pearsall, R. Kumar, D.A. Willins, J.S. Seehra, M.L. Sherman, A single ascending-dose study of muscle regulator ace-031 in healthy volunteers. Muscle Nerve 47, 416-423 (2013)
148. O. Guardiola, P. Lafuste, S. Brunelli, S. Iaconis, T. Touvier, P. Mourikis, K. De Bock, E. Lonardo, G. Andolfi, A. Bouché, G.L. Liguori, M.M. Shen, S. Tajbakhsh, G. Cossu, P. Carmeliet, G. Minchiotti, Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin. Proc. Natl. Acad. Sci. U S A 109, E3231-E3240 (2012)
149. H. Yamamoto, E.G. Williams, L. Mouchiroud, C. Cantó, W. Fan, M. Downes, C. Héligon, G.D. Barish, B. Desvergne, R.M. Evans, K. Schoonjans, J. Auwerx, NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827-839 (2011)